Our follow up investigation of CDCP1 exemplifies the utility of our technological pipeline, validates our approach of studying RAS signaling in a simple isogenic MCF10A model, and most importantly, provides a validated example of a cell surface marker for oncogenic RAS signaling in multiple cancer types. This evidence concerns the gene CDCP1 and cancer.